EX-99.1 2 d244671dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

LOGO    PRESS RELEASE            II-VI Incorporated
              375 Saxonburg Boulevard
              Saxonburg, PA 16056
             

II-VI Incorporated Reports Fiscal 2022 First Quarter Results

Record Quarterly Bookings and Backlog Drive Organic Growth

Approaching $1B Quarterly Bookings While Investing for Increasing Market Demand

 

   

Record Bookings of $939 million grew 43% year over year

 

   

Revenue of $795 million grew 9% year over year

 

   

Record Backlog of $1.4 billion

 

   

GAAP Net Earnings of $75 million

 

   

GAAP EPS of $0.50 grew 32% year over year

 

   

Non-GAAP EPS of $0.87 grew 4% year over year

 

   

Non-GAAP return on sales of 14.8% grew 7% year over year

PITTSBURGH, November 9, 2021 (GLOBE NEWSWIRE) — II-VI Incorporated (Nasdaq:IIVI) (“II-VI,” “We” or the “Company”) today reported results for its fiscal 2022 first quarter ended September 30, 2021.

“Fiscal year 2022 is starting with very strong momentum and sustainable demand signals that translated into another quarterly bookings record of $939 million and record backlog of $1.4 billion. We achieved $795 million in revenue, driven by year-over-year growth in virtually all our end markets. The quarter saw very strong performance in our Industrial business, growing in excess of 50% compared to Q1FY21. Moreover, our high speed 200/400/800G datacom and telecom revenues have significantly accelerated, growing nearly 70% sequentially. This growth was underpinned by our industry leading laser diode technologies that enabled the highest output power 400G coherent pluggable transceivers available in the marketplace,” said Dr. Vincent D. Mattera, Jr., Chief Executive.

Dr. Mattera continued, “Our customers are growing and demanding much more from us as the end markets we serve and the mega-market trends driving them, continue to accelerate. We are looking ahead and aggressively investing to serve these transformative and sustainable market trends consistent with our strategic plan.

“Our integration planning with Coherent is well underway, and we are even more excited about this transaction than we were six months ago. All integration planning teams are fully engaged and excited about the prospect of combining our complementary talent, technology platforms, and scale across the value chain. All remaining regulatory reviews are progressing on track, with China having formally commenced its review process in September. We continue to expect the transaction to close during the first calendar quarter of 2022. Our synergies on the Finisar transaction now exceed $180M, which are well ahead of schedule,” concluded Dr. Mattera.

 

T. 724.352.4455 | ii-vi.com

Page 1


LOGO

 

LOGO       PRESS RELEASE            II-VI Incorporated
                 375 Saxonburg Boulevard
                 Saxonburg, PA 16056
                

 

Table 1

Financial Metrics

$ Millions, except per share amounts and %

(Unaudited)

 

     Three Months Ended  
     Sept 30,
2021
    Jun 30,
2021
    Sept 30,
2020
 

Revenues

   $ 795.1   $ 808.0   $ 728.1

GAAP Gross Profit

   $ 316.2   $ 307.6   $ 286.6

Non-GAAP Gross Profit (2)

   $ 317.7   $ 311.7   $ 288.4

GAAP Operating Income (1)

   $ 95.1   $ 97.1   $ 101.1

Non-GAAP Operating Income (2)

   $ 150.2   $ 148.5   $ 138.9

GAAP Net Earnings

   $ 74.5   $ 82.3   $ 46.3

Non-GAAP Net Earnings (2)

   $ 117.7   $ 117.0   $ 100.4

GAAP Diluted Earnings Per Share

   $ 0.50   $ 0.59   $ 0.38

Non-GAAP Diluted Earnings Per Share (2)

   $ 0.87   $ 0.88   $ 0.84

Other Selected Financial Metrics

      

GAAP Gross margin

     39.8     38.1     39.4

Non-GAAP gross margin (2)

     40.0     38.6     39.6

GAAP Operating margin

     12.0     12.0     13.9

Non-GAAP operating margin (2)

     18.9     18.4     19.1

GAAP Return on sales

     9.4     10.2     6.4

Non-GAAP return on sales (2)

     14.8     14.5     13.8

 

(1)

GAAP Operating income is defined as earnings before income taxes, interest expense and other expense or income, net.

(2)

All non-GAAP amounts exclude certain adjustments for share-based compensation, acquired intangible amortization expense, certain one-time transaction expenses, and restructuring and related items. See Table 4 for the Reconciliation of GAAP measures to non-GAAP measures.

 

T. 724.352.4455 | ii-vi.com

Page 2


LOGO

 

LOGO    PRESS RELEASE            II-VI Incorporated
              375 Saxonburg Boulevard
              Saxonburg, PA 16056
             

 

Outlook

The outlook for the second fiscal quarter ending December 31, 2021 is revenue of $790 million to $840 million and earnings per diluted share on a non-GAAP basis of $0.75 to $0.95. This is at today’s exchange rate and today’s estimated tax impact of 19%. Both of these are subject to variability. For the non-GAAP earnings per share, we added back to the GAAP earnings pre-tax amounts of $21 million in amortization, $19 million in share-based compensation, and $21-26 million in transaction, integration and other related costs. Refer to page 16 for the share count range for the aforementioned outlook. Non-GAAP adjustments are by their nature highly volatile and we have low visibility as to the range that may be incurred in the future.

Conference Call & Webcast Information

The Company will host a conference call at 9:00 a.m. Eastern Time on Tuesday November 9, 2021 to discuss these results. Individuals wishing to participate in the webcast can access the event at the Company’s web site by visiting www.ii-vi.com or via https://tinyurl.com/IIVIQ1FY22EarningsRelease. If you wish to participate in the call, please dial +1 734-385-4977 or 877-316-5288. When you call, please enter Confirmation Code 1150469 and provide your name and company affiliation.

The call will be recorded, and a replay will be available to interested parties who are unable to attend the live event. This service will be available up to 11:59 p.m. EST on Friday, November 12, 2021, by dialing +1 734-385-4977 or 877-316-5288 and entering the ID number 1150469.

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in communications, industrial, aerospace & defense, semiconductor capital equipment, life sciences, consumer electronics, and automotive markets. Headquartered in Saxonburg, Pennsylvania, the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at www.ii-vi.com.

Forward-looking Statements

This press release contains forward-looking statements relating to future events and expectations that are based on certain assumptions and contingencies. The forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures.

The Company believes that all forward-looking statements made by it in this press release have a reasonable basis, but there can be no assurance that management’s expectations, beliefs, or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and global economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include but are not limited to: (i) the failure of any one or more of the assumptions

 

T. 724.352.4455 | ii-vi.com

Page 3


LOGO

 

LOGO    PRESS RELEASE            II-VI Incorporated
              375 Saxonburg Boulevard
              Saxonburg, PA 16056
             

 

stated above to prove to be correct; (ii) the risks relating to forward-looking statements and other “Risk Factors” discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 and additional risk factors that may be identified from time to time in future filings of the Company; (iii) the conditions to the completion of the Company’s pending business combination transaction with Coherent, Inc. (the “Transaction”) and the remaining equity investment by Bain Capital, LP, including the receipt of any required shareholder and regulatory approvals, and the risks that those conditions will not be satisfied in a timely manner or at all; (iv) the occurrence of any event, change or other circumstances that could give rise to an amendment or termination of the merger agreement relating to the Transaction, including the receipt by Coherent, Inc. (“Coherent”) of an unsolicited proposal from a third party; (v) the Company’s ability to finance the Transaction, the substantial indebtedness the Company expects to incur in connection with the Transaction and the need to generate sufficient cash flows to service and repay such debt; (vi) the possibility that the Company may be unable to achieve expected synergies, operating efficiencies and other benefits within the expected time-frames or at all and to successfully integrate Coherent’s operations with those of the Company; (vii) the possibility that such integration may be more difficult, time-consuming or costly than expected or that operating costs and business disruption (including, without limitation, disruptions in relationships with employees, customers or suppliers) may be greater than expected in connection with the Transaction; (viii) litigation and any unexpected costs, charges or expenses resulting from the Transaction; (ix) the risk that disruption from the Transaction materially and adversely affects the respective businesses and operations of the Company and Coherent; (x) potential adverse reactions or changes to business relationships resulting from the announcement, pendency or completion of the Transaction; (xi) the ability of the Company to retain and hire key employees; (xii) the purchasing patterns of customers and end users; (xiii) the timely release of new products, and acceptance of such new products by the market; (xiv) the introduction of new products by competitors and other competitive responses; (xv) the Company’s ability to assimilate recently acquired businesses, and realize synergies, cost savings, and opportunities for growth in connection therewith, together with the risks, costs, and uncertainties associated with such acquisitions; (xvi) the Company’s ability to devise and execute strategies to respond to market conditions; (xviii) the risks to realizing the benefits of investments in R&D and commercialization of innovations; (xix) the risks that the Company’s stock price will not trade in line with industrial technology leaders; and/or (xx) the risks of business and economic disruption related to the currently ongoing COVID-19 outbreak and any other worldwide health epidemics or outbreaks that may arise. The Company disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events or developments, or otherwise.

These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the joint proxy statement/prospectus included in the registration statement on Form S-4 (File No. 333-255547) filed with the SEC in connection with the Transaction (the “Form S-4”). While the list of factors discussed above and the list of factors presented in the Form S-4 are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward looking statements. Neither the Company nor Coherent assumes any obligation to publicly provide revisions or updates to any forward looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Use of Non-GAAP Financial Measures

The Company has disclosed financial measurements in this press release that present financial information considered to be non-GAAP financial measures. These measurements are not a substitute for GAAP measurements, although the Company’s management uses these measurements as an aid in monitoring the Company’s on-going financial performance. The non-GAAP net earnings, the non-GAAP earnings per share, the non-GAAP operating income, the non-GAAP gross profit, the non-GAAP internal research and development, the non-GAAP selling, general and administration, the non-GAAP interest and other (income) expense, and the non-GAAP income tax (benefit), measure earnings and operating income (loss), respectively, excluding non-recurring or unusual items that

 

T. 724.352.4455 | ii-vi.com

Page 4


LOGO

 

LOGO    PRESS RELEASE            II-VI Incorporated
              375 Saxonburg Boulevard
              Saxonburg, PA 16056
             

 

are considered by management to be outside the Company’s standard operation and excluding certain non-cash items. EBITDA is an adjusted non-GAAP financial measurement that is considered by management to be useful in measuring the profitability between companies within the industry by reflecting operating results of the Company excluding non-operating factors. There are limitations associated with the use of non-GAAP financial measures, including that such measures may not be entirely comparable to similarly titled measures used by other companies, due to potential differences among calculation methodologies. Thus, there can be no assurance whether (i) items excluded from the non-GAAP financial measures will occur in the future or (ii) there will be cash costs associated with items excluded from the non-GAAP financial measures. The Company compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by providing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures. Investors should consider adjusted measures in addition to, and not as a substitute for, or superior to, financial performance measures prepared in accordance with GAAP.

 

T. 724.352.4455 | ii-vi.com

Page 5


II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Earnings (Unaudited)

($000 except per share data)

 

     Three Months Ended  
     September 30,
2021
    September 30,
2020
 

Revenues

   $ 795,111   $ 728,084

Costs, Expenses & Other Expense

    

Cost of goods sold

     478,921     441,520

Internal research and development

     88,966     78,248

Selling, general and administrative

     132,174     107,186

Interest expense

     12,191     17,214

Other expense (income), net

     (7,582     24,339
  

 

 

   

 

 

 

Total Costs, Expenses, & Other Expense

     704,670     668,507
  

 

 

   

 

 

 

Earnings Before Income Taxes

     90,441     59,577

Income Taxes

     15,977     13,311
  

 

 

   

 

 

 

Net Earnings

   $ 74,464   $ 46,266
  

 

 

   

 

 

 

Less: Dividends on Preferred Stock

     17,082     6,440
  

 

 

   

 

 

 

Net Earnings available to the Common Shareholders

   $ 57,382   $ 39,826
  

 

 

   

 

 

 

Basic Earnings Per Share

   $ 0.54   $ 0.39
  

 

 

   

 

 

 

Diluted Earnings Per Share

   $ 0.50   $ 0.38
  

 

 

   

 

 

 

Average Shares Outstanding —Basic

     105,761     102,809

Average Shares Outstanding —Diluted

     115,849     105,247

 

T. 724.352.4455 | ii-vi.com

Page 6


II-VI Incorporated and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

($000)

 

     September 30,
2021
     June 30,
2021
 

Assets

     

Current Assets

     

Cash and cash equivalents

   $ 1,560,175    $ 1,591,892

Accounts receivable

     663,940      658,962

Inventories

     747,413      695,828

Prepaid and refundable income taxes

     14,652      13,095

Prepaid and other current assets

     64,771      67,617
  

 

 

    

 

 

 

Total Current Assets

     3,050,951      3,027,394

Property, plant & equipment, net

     1,242,093      1,242,906

Goodwill

     1,294,748      1,296,727

Other intangible assets, net

     697,209      718,460

Deferred income taxes

     33,495      33,498

Other assets

     197,366      193,665
  

 

 

    

 

 

 

Total Assets

   $ 6,515,862    $ 6,512,650
  

 

 

    

 

 

 

Liabilities, Mezzanine Equity and Shareholders’ Equity

     

Current Liabilities

     

Current portion of long-term debt

   $ 420,029    $ 62,050

Accounts payable

     295,003      294,486

Operating lease current liabilities

     27,087      25,358

Accruals and other current liabilities

     286,538      347,695
  

 

 

    

 

 

 

Total Current Liabilities

     1,028,657      729,589

Long-term debt

     956,377      1,313,091

Deferred income taxes

     81,173      73,962

Operating lease liabilities

     125,145      125,541

Other liabilities

     130,138      138,119
  

 

 

    

 

 

 

Total Liabilities

     2,321,490      2,380,302

Total Mezzanine Equity

     736,360      726,178

Total Shareholders’ Equity

     3,458,012      3,406,170
  

 

 

    

 

 

 

Total Liabilities, Mezzanine Equity and Shareholders’ Equity

   $ 6,515,862    $ 6,512,650
  

 

 

    

 

 

 

 

T. 724.352.4455 | ii-vi.com

Page 7


II-VI Incorporated and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

($000)

 

     Three Months Ended  
     September 30,  
     2021     2020  

Cash Flows from Operating Activities

    

Net cash provided by operating activities

   $ 52,336   $ 134,327
  

 

 

   

 

 

 

Cash Flows from Investing Activities

    

Additions to property, plant & equipment

     (47,565     (33,792

Purchases of businesses, net of cash acquired

     —         (36,064
  

 

 

   

 

 

 

Net cash used in investing activities

     (47,565     (69,856
  

 

 

   

 

 

 

Cash Flows from Financing Activities

    

Proceeds from issuance of common shares

     —         460,000

Proceeds from issuance of preferred shares

     —         460,000

Payments on borrowings under Term A Facility

     (15,513     (15,513

Payments on borrowings under Term B Facility

     —         (714,600

Payments on borrowings under Revolving Credit Facility

     —         (25,000

Equity issuance costs

     —         (36,092

Proceeds from exercises of stock options

     7,481     1,083

Payments in satisfaction of employees’ minimum tax obligations

     (13,017     (5,574

Payment of dividends

     (13,808     —    

Other financing activities

     (1,109     (1,329
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     (35,966     122,975
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     (522     3,493

Net increase (decrease) in cash and cash equivalents

     (31,717     190,939

Cash and Cash Equivalents at Beginning of Period

     1,591,892     493,046
  

 

 

   

 

 

 

Cash and Cash Equivalents at End of Period

   $ 1,560,175   $ 683,985
  

 

 

   

 

 

 

 

T. 724.352.4455 | ii-vi.com

Page 8


Table 2

Segment Revenues, GAAP Operating Income (Loss) & Margins, and

Non-GAAP Operating Income (Loss) & Margins*

$ Millions, except %

(Unaudited)

 

     Three Months Ended  
     Sept 30,
2021
    Jun 30,
2021
    Sept 30,
2020
 

Revenues:

      

Photonic Solutions

   $ 536.0   $ 549.7   $ 497.7

Compound Semiconductors

     259.1     258.3     230.4
  

 

 

   

 

 

   

 

 

 

Consolidated

   $ 795.1   $ 808.0   $ 728.1
  

 

 

   

 

 

   

 

 

 

GAAP Operating Income (Loss):

      

Photonic Solutions

   $ 56.5   $ 60.5   $ 50.4

Compound Semiconductors

     49.7     47.7     50.7

Unallocated and Other

     (11.2     (11.1     —    
  

 

 

   

 

 

   

 

 

 

Consolidated

   $ 95.1   $ 97.1   $ 101.1
  

 

 

   

 

 

   

 

 

 

Non-GAAP Operating Income:

      

Photonic Solutions

   $ 84.0   $ 87.4   $ 78.2

Compound Semiconductors

     66.3     61.1     60.7
  

 

 

   

 

 

   

 

 

 

Consolidated

   $ 150.2   $ 148.5   $ 138.9
  

 

 

   

 

 

   

 

 

 

GAAP Operating Margin:

      

Photonic Solutions

     10.5     11.0     10.1

Compound Semiconductors

     19.2     18.5     22.0

Consolidated

     12.0     12.0     13.9

Non-GAAP Operating Margin:

      

Photonic Solutions

     15.7     15.9     15.7

Compound Semiconductors

     25.6     23.7     26.4

Consolidated

     18.9     18.4     19.1

 

*

Amounts may not recalculate due to rounding.

 

T. 724.352.4455 | ii-vi.com

Page 9


Table 3

Reconciliation of Segment Non-GAAP Operating Income (Loss) to

GAAP Segment Operating Income (Loss)

$ Millions

(Unaudited)

 

     Three Months Ended  
     Sept 30,
2021
    Jun 30,
2021
    Sept 30,
2020
 

Non-GAAP Photonic Solutions Operating Income

   $ 84.0   $ 87.4   $ 78.2

Share-based compensation

     (9.6     (9.4     (10.5

Amortization of acquired intangibles

     (17.0     (17.3     (17.3

Restructuring, transaction expenses, and other

     (0.9     (0.2     —    
  

 

 

   

 

 

   

 

 

 

Photonic Solutions GAAP Operating Income

   $ 56.5   $ 60.5   $ 50.4
  

 

 

   

 

 

   

 

 

 

Non-GAAP Compound Semiconductors Operating Income

   $ 66.3   $ 61.1   $ 60.7

Share-based compensation

     (13.2     (9.3     (5.0

Amortization of acquired intangibles

     (3.4     (3.3     (2.9

Restructuring, transaction expenses, and other

     —         (0.8     (2.1
  

 

 

   

 

 

   

 

 

 

Compound Semiconductors GAAP Operating Income

   $ 49.7   $ 47.7   $ 50.7
  

 

 

   

 

 

   

 

 

 

Non-GAAP Unallocated and Other Operating Income (Loss)

   $ —     $ —     $ —  

Restructuring, transaction expenses, and other

     (11.2     (11.1     —    
  

 

 

   

 

 

   

 

 

 

Unallocated and Other GAAP Operating Income (Loss)

   $ (11.2   $ (11.1   $ —  
  

 

 

   

 

 

   

 

 

 
      
  

 

 

   

 

 

   

 

 

 

Total GAAP Operating Income

   $ 95.1   $ 97.1   $ 101.1
  

 

 

   

 

 

   

 

 

 
      
  

 

 

   

 

 

   

 

 

 

Non-GAAP Operating Income

   $ 150.2   $ 148.5   $ 138.9
  

 

 

   

 

 

   

 

 

 

 

*

Amounts may not recalculate due to rounding.

 

T. 724.352.4455 | ii-vi.com

Page 10


Table 4

Reconciliation of GAAP Measures to non-GAAP Measures

$ Millions

(Unaudited)

 

     Three Months Ended  
     Sept 30,
2021
    Jun 30,
2021
    Sept 30,
2020
 

Gross profit on GAAP basis

   $ 316.2   $ 307.6   $ 286.6

Share-based compensation

     1.5     3.4     1.8

Restructuring, transaction expenses, and other (1)

     —         0.7     —    
  

 

 

   

 

 

   

 

 

 

Gross profit on non-GAAP basis

   $ 317.7   $ 311.7   $ 288.4
  

 

 

   

 

 

   

 

 

 

Internal research and development on GAAP basis

   $ 89.0   $ 83.8   $ 78.2

Share-based compensation

     (2.3     (4.8     (2.6
  

 

 

   

 

 

   

 

 

 

Internal research and development on non-GAAP basis

   $ 86.7   $ 79.0   $ 75.6
  

 

 

   

 

 

   

 

 

 

Selling, general and administrative on GAAP basis

   $ 132.2   $ 126.7   $ 107.2

Share-based compensation

     (18.9     (10.3     (11.1

Amortization of acquired intangibles

     (20.4     (20.6     (20.2

Restructuring, transaction expenses, and other (1)

     (12.0     (11.5     (2.1
  

 

 

   

 

 

   

 

 

 

Selling, general and administrative on non-GAAP basis

   $ 80.9   $ 84.3   $ 73.8
  

 

 

   

 

 

   

 

 

 

Operating income on GAAP basis

   $ 95.1   $ 97.1   $ 101.1

Share-based compensation

     22.7     18.5     15.5

Amortization of acquired intangibles

     20.4     20.6     20.2

Restructuring, transaction expenses, and other (1)

     12.0     12.2     2.1
  

 

 

   

 

 

   

 

 

 

Operating income on non-GAAP basis

   $ 150.2   $ 148.5   $ 138.9
  

 

 

   

 

 

   

 

 

 

 

T. 724.352.4455 | ii-vi.com

Page 11


Table 4

Reconciliation of GAAP Measures to non-GAAP Measures (Continued)

$ Millions

(Unaudited)

 

     Three Months Ended  
     Sept 30,
2021
    Jun 30,
2021
    Sept 30,
2020
 

Interest and other (income) expense, net on GAAP basis

   $ 4.6   $ 3.9   $ 41.5

Foreign currency exchange gains (losses), net

     4.9     (1.2     (4.7

Gain on investment

     —         10.9     —    

Debt extinguishment expense (2)

     —         —         (24.7
  

 

 

   

 

 

   

 

 

 

Interest and other (income) expense, net on non-GAAP basis

   $ 9.5   $ 13.6   $ 12.1
  

 

 

   

 

 

   

 

 

 

Income taxes on GAAP basis

   $ 16.0   $ 11.0   $ 13.3

Tax impact of non-GAAP measures

     7.1     6.8     13.1
  

 

 

   

 

 

   

 

 

 

Income taxes on non-GAAP basis

   $ 23.1   $ 17.8   $ 26.4
  

 

 

   

 

 

   

 

 

 

Net earnings on GAAP basis

   $ 74.5   $ 82.3   $ 46.3

Share-based compensation

     22.7     18.5     15.5

Amortization of acquired intangibles

     20.4     20.6     20.2

Foreign currency exchange (gains) losses

     (4.9     1.2     4.7

Debt extinguishment expense (2)

     —         —         24.7

Other Gains

     —         (10.9     —    

Tax impact of non-GAAP measures and fair value adjustments

     (7.1     (6.8     (13.1

Restructuring, transaction expenses, and other(1)

     12.0     12.2     2.1
  

 

 

   

 

 

   

 

 

 

Net earnings on non-GAAP basis

   $ 117.7   $ 117.0   $ 100.4
  

 

 

   

 

 

   

 

 

 
Per share data:       

Net earnings on GAAP basis

      

Basic Earnings Per Share

   $ 0.54   $ 0.62   $ 0.39

Diluted Earnings Per Share

   $ 0.50   $ 0.59   $ 0.38

Net earnings on non-GAAP basis

      

Basic Earnings Per Share

   $ 0.95   $ 0.95   $ 0.91

Diluted Earnings Per Share

   $ 0.87   $ 0.88   $ 0.84

 

*

Amounts may not recalculate due to rounding.

 

(1)

During fiscal year 2022, transaction costs primarily represent fees incurred in relation to the pending Coherent acquisition and customer settlements from acquired liabilities of previous acquisitions. During fiscal year 2021, transaction costs primarily represent transaction expenses related to the Ascatron acquisition.

(2)

The Company recorded debt extinguishment expense of $24.7 million in connection with the extinguishment of the Term B Loan Facility during the three months ended September 30, 2020.

 

T. 724.352.4455 | ii-vi.com

Page 12


Table 5

Reconciliation of GAAP Net Income (Loss), EBITDA and Adjusted EBITDA

$ Millions

(Unaudited)

 

     Three Months Ended  
     Sept 30,
2021
    Jun 30,
2021
    Sept 30,
2020
 

Net earnings on GAAP basis

   $ 74.5   $ 82.3   $ 46.3

Income taxes

     16.0     10.9     13.3

Depreciation and amortization

     69.7     70.2     64.7

Interest expense

     12.2     14.1     17.2
  

 

 

   

 

 

   

 

 

 

EBITDA (1)

   $ 172.4   $ 177.5   $ 141.5
  

 

 

   

 

 

   

 

 

 

EBITDA margin

     21.7     22.0     19.4

Stock based compensation

     22.7     18.5     15.5

Foreign currency exchange (gains) losses

     (4.9     1.2     4.7

Debt extinguishment expense

     —         —         24.7

Restructuring expenses, transaction expenses, and other

   $ 12.0   $ 2.8   $ 2.1
  

 

 

   

 

 

   

 

 

 

Adjusted EBITDA (2)

   $ 202.2   $ 200.0   $ 188.5
  

 

 

   

 

 

   

 

 

 

Adjusted EBITDA margin

     25.4     24.8     25.9

 

*

Amounts may not recalculate due to rounding.

 

(1)

EBITDA is defined as earnings before interest, income taxes, depreciation and amortization.

(2)

Adjusted EBITDA excludes non-GAAP adjustments for share-based compensation, certain one-time transaction expenses, the impact of restructuring and related items, debt extinguishment charges, expenses incurred for asset retirement obligations and the impact of foreign currency exchange gains and losses and COVID related costs incurred during fiscal year 2021.

 

T. 724.352.4455 | ii-vi.com

Page 13


Table 6

GAAP Earnings Per Share Calculation

$ Millions

(Unaudited)

 

     Three Months Ended  
     Sept 30,
2021
    Jun 30,
2021
    Sept 30,
2020
 

Numerator

      

Net earnings

   $ 74.5   $ 82.3   $ 46.3

Deduct Series A preferred stock dividends

     (6.9     (6.9     (6.4

Deduct Series B redeemable preferred dividends

     (10.2     (10.0     —    
  

 

 

   

 

 

   

 

 

 

Basic earnings available to common shareholders

   $ 57.4   $ 65.4   $ 39.8
  

 

 

   

 

 

   

 

 

 

Effect of dilutive securities:

      

Add back interest on Convertible Senior Notes Due 2022

   $ 0.5   $ 3.1   $ —  
  

 

 

   

 

 

   

 

 

 

Diluted earnings available to common shareholders

   $ 57.9     68.5     $ 39.8
  

 

 

   

 

 

   

 

 

 

Denominator

      

Weighted average shares

     105.8       105.0     102.8  

Effect of dilutive securities:

      

Common stock equivalents

     2.8       3.9       2.4

0.25% Convertible Senior Notes due 2022

     7.3     7.3       —    
  

 

 

   

 

 

   

 

 

 

Diluted weighted average common shares

     115.8       116.2       105.2
  

 

 

   

 

 

   

 

 

 

Basic earnings per common share

   $ 0.54   $ 0.62   $ 0.39
  

 

 

   

 

 

   

 

 

 

Diluted earnings per common share

   $ 0.50   $ 0.59   $ 0.38
  

 

 

   

 

 

   

 

 

 

 

*

Amounts may not recalculate due to rounding.

 

T. 724.352.4455 | ii-vi.com

Page 14


Table 7

Non-GAAP Earnings Per Share Calculation

$ Millions

(Unaudited)

 

     Three Months Ended  
     Sept 30,
2021
    Jun 30,
2021
    Sept 30,
2020
 

Numerator

      

Net earnings on non-GAAP basis

   $ 117.7   $ 117.0   $ 100.4

Deduct Series A preferred stock dividends

     (6.9     (6.9     (6.4

Deduct Series B redeemable preferred dividends

     (10.2     (10.0     —    
  

 

 

   

 

 

   

 

 

 

Basic earnings available to common shareholders

   $ 100.6   $ 100.2   $ 94.0
  

 

 

   

 

 

   

 

 

 

Effect of dilutive securities:

      

Add back interest on Convertible Senior Notes Due 2022

   $ 0.5   $ 3.1   $ 3.1

Add back Series A preferred stock dividends

     6.9     6.9     6.4
  

 

 

   

 

 

   

 

 

 

Diluted earnings available to common shareholders

   $ 108.0   $ 110.1   $ 103.5
  

 

 

   

 

 

   

 

 

 
Denominator       

Weighted average shares

     105.8       105.0       102.8  

Effect of dilutive securities:

      

Common stock equivalents

     2.8       3.9       2.4  

0.25% Convertible Senior Notes due 2022

     7.3       7.3       7.3  

Series A Mandatory Convertible Preferred Stock

     8.9       8.9       10.4  
  

 

 

   

 

 

   

 

 

 

Diluted weighted average common shares

     124.8       125.1     123.0
  

 

 

   

 

 

   

 

 

 

Basic earnings per common share on non-GAAP basis

   $ 0.95   $ 0.95   $ 0.91
  

 

 

   

 

 

   

 

 

 

Diluted earnings per common share on non-GAAP basis

   $ 0.87   $ 0.88   $ 0.84
  

 

 

   

 

 

   

 

 

 

 

*

Amounts may not recalculate due to rounding.

 

T. 724.352.4455 | ii-vi.com

Page 15


Table 8

Example EPS Calculations(1)

$ Millions

 

     Hypothetical Earnings Level for Q2 FY22  

Non-GAAP net earnings

   $ 104.0   $ 116.0   $ 128.0

Deduct Series A preferred stock dividends

     (6.9     —         —    

Deduct Series B redeemable preferred dividends

     (10.3     (10.3     (10.3

Add back interest on Convertible Senior Notes Due 2022

     0.6     0.6     0.6
  

 

 

   

 

 

   

 

 

 

Non-GAAP net earnings available to common shareholders

   $ 87.4   $ 106.3   $ 118.3
  

 

 

   

 

 

   

 

 

 

Diluted weighted average common shares

     116.0       124.9       124.9  

Diluted earnings per common share on non-GAAP basis

   $ 0.75   $ 0.85   $ 0.95
  

 

 

   

 

 

   

 

 

 

 

(1)

The Company does not provide reconciliations of the hypothetical non-GAAP net earnings and hypothetical diluted non-GAAP EPS presented in this table. The Company is unable, without unreasonable efforts, to forecast certain items required to develop meaningful GAAP financial measures that are comparable to these purely hypothetical figures, which are provided solely to illustrate how the Company would calculate diluted non-GAAP EPS under different factual scenarios.

CONTACT:

Mary Jane Raymond

Treasurer and Chief Financial Officer

investor.relations@ii-vi.com

www.ii-vi.com/contact-us

 

T. 724.352.4455 | ii-vi.com

Page 16